NEVVI Medicare utilization intelligence
or

← back

Provider profile

DRENGLER, RONALD M.D.

Medical Oncology · NPI 1265459168 · SAN ANTONIO, TX

1
Groups
82
Codes · 2024
261,710
Disclosed services

DRENGLER, RONALD is a Medical Oncology in SAN ANTONIO, TX, a member of 1 medical group, who billed 82 distinct codes to Medicare Part B in 2024.

Groups: SOUTH TEXAS ONCOLOGY AND HEMATOLOGY, PLLC (SAN ANTONIO, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

261,710
disclosed services
82
codes billed to Medicare Part B
Prior year · CY2023 223,535 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9299 Injection, nivolumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9259 Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg
J0897 Injection, denosumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J9228 Injection, ipilimumab, 1 mg
J0461 Injection, atropine sulfate, 0.01 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
J1437 Injection, ferric derisomaltose, 10 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
83615 Lactate dehydrogenase (enzyme) level
J2469 Injection, palonosetron hcl, 25 mcg
J0640 Injection, leucovorin calcium, per 50 mg
J3480 Injection, potassium chloride, per 2 meq
80053 Blood test, comprehensive group of blood chemicals
J9196 Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
J9206 Injection, irinotecan, 20 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2919 Injection, methylprednisolone sodium succinate, 5 mg
36415 Insertion of needle into vein for collection of blood sample
J9190 Injection, fluorouracil, 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96372 Injection of drug or substance under skin or into muscle
96375 Injection of additional new drug or substance into vein
96417 Administration of additional new drug or substance into vein, 1 hour or less
J3475 Injection, magnesium sulfate, per 500 mg
J9060 Injection, cisplatin, powder or solution, 10 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
82378 Carcinoembryonic antigen (cea) protein level
83735 Magnesium level
J9045 Injection, carboplatin, 50 mg
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
84439 Thyroxine (thyroid chemical), free
96415 Administration of chemotherapy into vein, each additional hour
J2468 Injection, palonosetron hydrochloride (avyxa), not therapeutically equivalent to j2469, 25 micrograms
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
J3490 Unclassified drugs
82550 Creatine kinase (cardiac enzyme) level, total
84481 Thyroid hormone, t3 measurement, free
84484 Troponin (protein) analysis, quantitative
J1200 Injection, diphenhydramine hcl, up to 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82150 Amylase (enzyme) level
83690 Lipase (fat enzyme) level
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
J7030 Infusion, normal saline solution , 1000 cc
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
83540 Iron level
83550 Iron binding capacity
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
82728 Ferritin (blood protein) level
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96523 Irrigation of implanted venous access drug delivery device
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
85045 Red blood count, automated test
82607 Cyanocobalamin (vitamin b-12) level
84153 Psa (prostate specific antigen) measurement, total
82784 Gammaglobulin (immune system protein) measurement
96360 Infusion into a vein for hydration, 31-60 minutes
96361 Infusion into a vein for hydration, each additional hour
J2150 Injection, mannitol, 25% in 50 ml
96411 Administration of additional new drug or substance into vein using push technique
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
81002 Urinalysis, manual test
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
84100 Phosphate level
84443 Blood test, thyroid stimulating hormone (tsh)
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
87340 Detection test by immunoassay technique for hepatitis b surface antigen
86704 Hepatitis b core antibody measurement
85610 Blood test, clotting time

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.